#China #Shanghai #CPHI #global pharma #PMEC China

CPHI & PMEC China: A New Horizon for Global Pharma

The upcoming CPHI & PMEC China, scheduled from June 24-26, 2025, at the new International Exhibition Center in Shanghai, promises to be a landmark event for the pharmaceutical industry. With over 90,000 expected participants, including 12,000 senior executives from around the world, this edition is projected to become the largest pharmaceutical gathering in Asia's history. This surge in attendance reflects not only the increasing global interest in the pharmaceutical sector but also indicates a significant turnaround following a series of positive developments in global trade and pharmaceutical investments.

A Surge in International Participation

The robust international participation can be attributed to the easing of tariffs, improved valuations in the pharmaceutical sector, and rising investments across the industry. A notable trend is the increasing interest from Western pharmaceutical companies in Chinese biotech assets, driven by a desire to tap into the Chinese domestic market and explore licensure opportunities globally. Furthermore, the Middle Eastern nations are stepping up their presence, with Gulf countries implementing strategies to establish regional manufacturing centers, thereby joining larger delegations from India and the USA.

"The fundamentals of the industry remain incredibly strong, with global pharmaceutical companies achieving record discovery goals and returning to growth," expressed Natasha Jennings, Global Growth Marketing Lead. "International attendees are leveraging China's expansive network of ingredient, manufacturing, and raw material enterprises to propel global manufacturing industry growth."

Opportunities for Industry Stakeholders

The audience at this prestigious event showcases the industry's strong mobilization, with 80% of international attendees having purchasing power, and more than 50% occupying leadership positions. The event will feature several supplementary programs, including a program for natural extracts buyers on June 23 and another for pharmaceutical machinery buyers on June 24-25. Among the highlights are the CPHI Celebration Awards, a special conference, the 10th Biopharmaceutical Outlook Summit, an innovation gallery, and regional factory tours.

With over 230,000 square meters of exhibition space accommodating 3,500 exhibitors from 150 countries, the event comprises 12 specialized zones, including new areas focusing on Biotechnologies and Precision Fluid and Equipment.

"Global leaders are now seeking to expand their partner networks in China, establishing primary, secondary, and reserve suppliers for long-term strategic planning. With improvements in trade relationships, we are witnessing a renaissance of global pharmaceutical partnerships," Jennings further elaborated.

Conclusion

As the CPHI & PMEC China approaches, it signifies not merely a gathering of industry professionals, but a pivotal moment for the global pharmaceutical market. With the strengthened collaborative spirit and prospects for growth, attendees are encouraged to seize opportunities that may define the future of healthcare solutions on a global scale. To register, please visit CPHI Registration.

For media inquiries, please contact Winnie Xu at [email protected]